202 related articles for article (PubMed ID: 12644317)
21. Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies.
Silvestre R; Cordeiro-da-Silva A; Tavares J; Sereno D; Ouaissi A
Immunology; 2006 Dec; 119(4):529-40. PubMed ID: 17026719
[TBL] [Abstract][Full Text] [Related]
22. Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.
Daneshvar H; Molaei MM; Kamiabi H; Burchmore R; Hagan P; Stephen Phillips R
Parasite Immunol; 2010; 32(11-12):722-30. PubMed ID: 21039612
[TBL] [Abstract][Full Text] [Related]
23. Use of ELISA employing homologous and heterologous antigens for the detection of IgG and subclasses (IgG1 and IgG2) in the diagnosis of canine visceral leishmaniasis.
Ribeiro FC; Schubach Ade O; Mouta-Confort E; Pacheco TM; Madeira Mde F; Abboud LC; Honse Cde O; Alves AS; Marzochi MC
Rev Inst Med Trop Sao Paulo; 2011; 53(5):283-9. PubMed ID: 22012455
[TBL] [Abstract][Full Text] [Related]
24. [Research progress on the diagnosis technology of canine visceral leishmaniasis].
Ding D; Wang JY
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Oct; 30(5):406-10. PubMed ID: 23484286
[TBL] [Abstract][Full Text] [Related]
25. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
[TBL] [Abstract][Full Text] [Related]
26. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
[TBL] [Abstract][Full Text] [Related]
27. A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis.
Carson C; Antoniou M; Ruiz-Argüello MB; Alcami A; Christodoulou V; Messaritakis I; Blackwell JM; Courtenay O
Vaccine; 2009 Feb; 27(7):1080-6. PubMed ID: 19095029
[TBL] [Abstract][Full Text] [Related]
28. Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis.
Rodríguez-Cortés A; Fernández-Bellón H; Ramis A; Ferrer L; Alberola J; Solano-Gallego L
Vet Immunol Immunopathol; 2007 Apr; 116(3-4):190-8. PubMed ID: 17321600
[TBL] [Abstract][Full Text] [Related]
29. Relationships between specific antibody responses and clinical signs of dogs living in Tunisian endemic areas of canine leishmaniasis caused by Leishmania infantum.
Mhadhbi M; Chaabouni A; Bouabid C; Sassi A
Acta Trop; 2021 Jun; 218():105906. PubMed ID: 33775627
[TBL] [Abstract][Full Text] [Related]
30. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
de Andrade RA; Reis AB; Gontijo CM; Braga LB; Rocha RD; Araújo MS; Vianna LR; Martins-Filho OA
Vet Immunol Immunopathol; 2007 Mar; 116(1-2):85-97. PubMed ID: 17287029
[TBL] [Abstract][Full Text] [Related]
31. Immunoglobulin G and E responses in various stages of canine leishmaniosis.
Iniesta L; Gállego M; Portús M
Vet Immunol Immunopathol; 2005 Jan; 103(1-2):77-81. PubMed ID: 15626463
[TBL] [Abstract][Full Text] [Related]
32. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.
Soto M; Requena JM; Quijada L; Perez MJ; Nieto CG; Guzman F; Patarroyo ME; Alonso C
Clin Exp Immunol; 1999 Feb; 115(2):342-9. PubMed ID: 9933463
[TBL] [Abstract][Full Text] [Related]
33. Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum infection.
Moshfe A; Mohebali M; Edrissian G; Zarei Z; Akhoundi B; Kazemi B; Jamshidi S; Mahmoodi M
Acta Trop; 2009 Nov; 112(2):101-5. PubMed ID: 19595664
[TBL] [Abstract][Full Text] [Related]
34. A cross-sectional study on canine Leishmania (L.) infantum chagasi infection in Amazonian Brazil ratifies a higher prevalence of specific IgG-antibody response than delayed-type hypersensitivity in symptomatic and asymptomatic dogs.
Silveira FT; Carneiro LA; Ramos PK; Chagas EJ; Lima LV; Campos MB; Laurenti MD; Gomes CM; Corbett CE
Parasitol Res; 2012 Oct; 111(4):1513-22. PubMed ID: 22706905
[TBL] [Abstract][Full Text] [Related]
35. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
[TBL] [Abstract][Full Text] [Related]
36. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi.
Reis AB; Teixeira-Carvalho A; Vale AM; Marques MJ; Giunchetti RC; Mayrink W; Guerra LL; Andrade RA; Corrêa-Oliveira R; Martins-Filho OA
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):102-16. PubMed ID: 16621021
[TBL] [Abstract][Full Text] [Related]
37. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.
Fernandes AP; Costa MM; Coelho EA; Michalick MS; de Freitas E; Melo MN; Luiz Tafuri W; Resende Dde M; Hermont V; Abrantes Cde F; Gazzinelli RT
Vaccine; 2008 Oct; 26(46):5888-95. PubMed ID: 18786587
[TBL] [Abstract][Full Text] [Related]
38. Profile of anti-Leishmania antibodies related to clinical picture in canine visceral leishmaniasis.
de Freitas JC; Lopes-Neto BE; de Abreu CR; Coura-Vital W; Braga SL; Reis AB; Nunes-Pinheiro DC
Res Vet Sci; 2012 Oct; 93(2):705-9. PubMed ID: 22226072
[TBL] [Abstract][Full Text] [Related]
39. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum.
Molano I; Alonso MG; Mirón C; Redondo E; Requena JM; Soto M; Nieto CG; Alonso C
Vet Immunol Immunopathol; 2003 Mar; 92(1-2):1-13. PubMed ID: 12628759
[TBL] [Abstract][Full Text] [Related]
40. Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans.
Santos TTO; Cardoso MS; Machado AS; Siqueira WF; Ramos FF; Oliveira-da-Silva JA; Tavares GSV; Lage DP; Costa LE; de Freitas CS; Martins VT; Bandeira RS; Chávez-Fumagalli MA; Lyon S; Moreira RLF; de Magalhães-Soares DF; Silveira JAG; Tupinambás U; Caligiorne RB; Chaves AT; Rocha MOC; Fujiwara RT; Coelho EAF
Microb Pathog; 2019 Dec; 137():103783. PubMed ID: 31600536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
